Female infertility refers to infertility in female humans. It affects an estimated 48 million women with the highest prevalence of infertility affecting people in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia. Infertility is caused by many sources, including nutrition, diseases, and other malformations of the uterus. Infertility affects women from around the world.
The Female infertility Treatment Program includes the following:
- 10 Nights of hospitalization. (The Hospitalization will include accommodation, nursing care and medical assistance, as well as three course meals).
- Laboratory Tests which includes:
– Erythrocyte sedimentation rate.
– Differential white blood cell count
– Blood type and RH factor Complete coagulation test
– CBC test
– Quantitative serology test
– Venereal Disease Research Laboratory (VDRL) test
– HIV test
– Cyturia test
– Glycemia test
– Creatinine test
– FSH (Follicle Stimulating Hormone) and LH (Lutenizing Hormone) Estrogen test
– Progesterone and prolactin test
- Other tests: Vaginal discharge and vaginal cytology. Sperm penetration test and cervical Test
- Imaging studies: Hysterosalpingography. Skull and Sella radiography. Transvaginal ultrasound.
- Instrumentation and diagnostic examination: Contrasted Laparoscopy.